- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Instruments
Snapshot for Thoratec Corp (THOR)
| Open: | 31.4700 | Day's Range: | 31.1800 - 31.7900 | Volume: | 783,732 |
|---|---|---|---|---|---|
| Previous Close: | 31.4900 | 52wk Range: | 29.3900 - 39.8600 | 1-Yr Rtn: | +0.93% |
Key Statistics for THOR
| Current P/E Ratio (ttm) | 23.0073 |
|---|---|
| Estimated P/E(12/2013) | 17.7678 |
| Relative P/E vs. SPX | 1.4112 |
| Earnings Per Share (USD) (ttm) | 1.3700 |
| Est. EPS (USD) (12/2013) | 1.7740 |
| Est. PEG Ratio | 2.0427 |
| Market Cap (M USD) | 1,807.05 |
| Shares Outstanding (M) | 57.33 |
| 30 Day Average Volume | 845,976 |
| Price/Book (mrq) | 2.9271 |
| Price/Sale (ttm) | 3.8092 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/01/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for THOR
Company Profile & Key Executives for THOR
Thoratec Corporation researches, develops, manufactures, and markets medical devices for circulatory support and vascular graft applications. The Company's products include a ventricular assist device, an implantable left ventricular heart assist device, a vascular access graft, and a coronary artery bypass graft. Thoratec also supplies whole-blood coagulation testing equipment.
| Neil F DimickNon-Executive Chairman | Gerhard F Burbach "Gary"President/CEO |
| David A LehmanSenior VP/Secy/Gen Cnsl | Taylor C HarrisVP/CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
THOR News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page